Multiple clinical studies have confirmed that excessive Trans fatty acids (TFAs) consumption increases the probability of developing NASH and excessive TFA intake reduces the sensitivity of fat cells to insulin, which in turn increases the insulin consumption and the pancreatic load. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.